CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9,044 enrolled
Drug / intervention
bariatric surgery patientsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03556995
NCT03556995N/ACompleted

Score Scale to Assess Risk of Bleeding in Bariatric Surgery

Assuta Medical Center·observational·Posted Jun 14, 2018·Updated May 8, 2026

In Brief

An observational study evaluating bariatric surgery patients for Obesity and 3 related conditions. Completed, enrolled 9,044 participants across 1 site.

Detailed Summary

As bleeding is a major risk in bariatric surgeries, The study aimed to find any predictors to such bleeding within the surgery or 30 days after surgery. The study is a retrospective study collecting patients data, surgeons data, and hospitals data in order to find if any of the factors influencing patients, surgeons or hospitals, has to do with bleeding in these surgeries and if it does impact bleeding in what way. The goal is finding a predictor that it's neutralizing may prevent bleeding in bariatric surgeries.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 14, 2018
Enrollment StartJan 1, 2013
Primary CompletionMar 31, 2016
Study CompletionJan 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 8.0 years ago

Interventions

bariatric surgery patientsother